We safely navigate and medically manage the whole GLP-1 weight loss journey
A medically managed approach to weight loss
We have partnered with Eli Lily Pharmaceuticals who manufacture MOUNJARO® to introduce a structured, medically managed weight loss service.
Our focus is on helping individuals achieve sustainable weight loss through a safe and effective programme, supervised by a team of lifestyle medics.
Initial Appointment
During your first appointment, we will carry out the following:
- Suitability Assessment: A thorough evaluation to determine if this programme is right for you.
- Goal Setting: We’ll work with you to set realistic and achievable weight loss goals.
- Pre-Treatment Lab Work: A comprehensive set of lab tests to ensure a safe and personalised treatment approach.
- Prescription: You’ll receive a prescription tailored to your needs, based on the outcomes of the consultation and lab work.
Why Regent Street Clinic?
- Medically Supervised: Your weight loss journey is overseen by experienced doctors/clinicians, ensuring a focus on safety and effectiveness
- Ongoing Support: We provide regular check-ins and support to help you stay on track
- Multidisciplinary Team: Our team includes doctors, nurses, nutritionists, personal trainers, cognitive behavioural therapists (CBT), and lifestyle coaches. This integrated approach ensures you receive the most comprehensive supported care
- Easy access to the GLP-1 medication
- We have partnered with Eli Lily, the manufacturers of Mounjaro® so the support is second to none
- Mounjaro® is a weekly self–injectable pen used for weight loss. It contains Tirzepatide which works by regulating blood sugar and energy balance levels, helping to reduce appetite and prevent cravings
- Mounjaro® is an injection pen used for weight loss. Here’s how it works: GLP-1 helps to regulate blood sugar levels by making you feel less hungry and prevent cravings. It also slows down the emptying of the stomach to keep you feeling fuller for longer. GIP is another hormone that regulates energy balance in brain and fat cells, enhancing the GLP-1 effect of suppressing your appetite and improving sugar control. If you’re wondering how much weight you can lose on Mounjaro®, clinical trials have shown that patients could achieve at least 20% weight loss after using MOUNJARO® for 72 weeks (18 months) when combined with healthy lifestyle changes
- Prior to starting treatment patients must have a thorough health screening assessment as the weight loss injections can cause serious side effects in people who are predisposed to pancreatitis, liver and kidney disease, those with a personal or family history of thyroid cancer and other metabolic disorders
- The complete package, includes the initial appointment, the pre-treatment assessment, the full GOLD blood laboratory screening bloods and goal setting – the ”full pre-treatment MOT”
About Mounjaro®
We offer Mounjaro®, a medication specifically licensed for weight loss in non-diabetics.
- Effective Results: Clinical studies have shown that Mounjaro® can lead to over 20% weight loss, surpassing many other treatments currently available.
- How It Works: Mounjaro® is a dual-acting GLP1 and GIP medication, which makes it more effective than GLP1 alone by targeting both blood sugar regulation and appetite control.
Ready to take the next step? Click here to book your initial consultation and start your weight loss journey with Regent Street Clinic™
Treatment Summary
Initial Appointment: Physical, emotional and lifestyle assessment with our medical team and includes goal setting and our thorough GOLD blood screening panel.
Monthly Follow-Up Appointments: Ongoing monthly reviews to monitor progress, titrate treatment doses, and to provide tailored support.
Optional Additional Support: CBT , personal training, lifestyle coaching, or nutritionist support.
Patient Profile:
Female, 66 years old
Height: 159 cm
Starting weight: 88 kg (BMI 34.8)
Latest weight: 72 kg
This patient achieved a 16 kg weight loss in just over 5 months with safe, structured support from our clinic. Her BMI reduced from 34.8 to 28.5, and her waist measurement decreased by over 3 inches. This steady progress highlights the effectiveness of our tailored medical weight loss programme.
Patient Profile:
Female, 53 years old
Menopausal, struggling with weight management
Starting weight: 91 kg (BMI 33.9)
Goal weight: 70 kg (achieved on 26 Aug 2025)
This menopausal patient successfully reduced her weight from 91 kg (BMI 33.9) to 70 kg, achieving her goal weight in under 7 months. Alongside weight loss, her waist measurement reduced by more than 5 inches, reflecting improvements in both health and body confidence